Covid-19 roundup: Sanofi & Re­gen­eron de­liv­er dis­ap­point­ing news on IL-6; Alex Azar ru­mors are swirling at HHS

A pop­u­lar the­o­ry for how to treat some of the worst symp­toms of Covid-19 stum­bled to­day.

Sanofi and Re­gen­eron an­nounced that a Phase II/III tri­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.